Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProtiSorb is a proprietary protein-scaffold delivery technology developed by Ultra Botanica, designed to significantly enhance the bioavailability and absorption of poorly soluble botanical compounds, most notably curcumin. The technology utilizes a protein matrix (typically whey protein) to encapsulate active molecules, maintaining them in a monomeric state and preventing the formation of large, poorly absorbed crystals. This approach allows for high plasma concentrations of the active ingredient following oral administration. ProtiSorb is the foundational technology for Ultra Botanica's supplement line, including UltraCur and ONCO-ADJUNCT, which are marketed for their anti-inflammatory and antioxidant properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProtiSorb.